Literature DB >> 21777404

Pharmacokinetics of losartan and its active carboxylic acid metabolite E-3174 in five ethnic populations of China.

L Yang1, T Guo, D-Y Xia, L-S Zhao.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Interethnic variability in drug pharmacokinetics is well known. Our aim was to investigate whether the pharmacokinetics of losartan and its active carboxylic acid metabolite E-3174 vary between subjects of five Chinese ethnicities (Han, Mongolian, Korean, Hui and Uigur).
METHODS: Fifty healthy subjects (five men and five women of each ethnicity) were recruited, and each received 50-mg dose of losartan in tablet form. Fourteen blood samples were collected for each subject over a 24-h period after drug administration. The concentrations of losartan and its active carboxylic acid metabolite E-3174 in plasma were determined by high-performance liquid chromatography/fluorescence (HPLC/FLU) method, and the pharmacokinetic parameters were calculated by DAS 2.0 software and compared by SPSS 16.0 software. Pharmacokinetic parameters, including area under the curve from 0h to the last measured point 24h [AUC((0-24))], area under the curve from 0h to infinite time [AUC((0-∞))], peak plasma concentration (C(max) ), time to reach C(max) (t(max) ), oral clearance (CL), oral volume of distribution (V(d)) and elimination half-life (t(1/2) ), were determined following a single oral dose of losartan. RESULTS AND DISCUSSION: The t(1/2) values of losartan and its active carboxylic acid metabolite E-3174 showed significant differences across the five ethnicities. After normalization by weight, no ethnicity-based difference was noted in the pharmacokinetic parameters of losartan. However, there were significant differences in C(max) and V(d) of the active carboxylic acid metabolite E-3174 for Han and Mongolian subjects, compared with the other three ethnic groups. There was a high linear correlation between weight and C(max) , AUC((0-24)) , AUC((0-∞)) , CL and V(d) . WHAT IS NEW AND
CONCLUSION: Ethnicity was associated with significant differences in the single-dose pharmacokinetics of losartan's active carboxylic acid metabolite E-3174 in healthy subjects of the five main ethnic groups in China.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777404     DOI: 10.1111/j.1365-2710.2011.01279.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Ethnic-specific in vitro-in vivo extrapolation and physiologically based pharmacokinetic approaches to predict cytochrome P450-mediated pharmacokinetics in the Chinese population: opportunities and challenges.

Authors:  Guo-Fu Li; Guo Yu; Hong-Xia Liu; Qing-Shan Zheng
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

2.  Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.

Authors:  Tomoko Hasunuma; Masahiro Tohkin; Nahoko Kaniwa; In-Jin Jang; Cui Yimin; Masaru Kaneko; Yoshiro Saito; Masahiro Takeuchi; Hiroshi Watanabe; Yasushi Yamazoe; Yoshiaki Uyama; Shinichi Kawai
Journal:  Br J Clin Pharmacol       Date:  2016-03-14       Impact factor: 4.335

3.  Inter-ethnic differences in pharmacokinetics-is there more that unites than divides?

Authors:  Olusola Olafuyi; Nikita Parekh; Jacob Wright; Jennifer Koenig
Journal:  Pharmacol Res Perspect       Date:  2021-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.